A new study may have found a potentially easier, less disruptive and more effective way to treat the second leading cause of ...

Approximately one in eight American men will be diagnosed with prostate cancer during their lifetime. For most of them, if ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Advances in radiotherapy are rapidly transforming how prostate cancer is treated, offering patients more precise, less invasive options that can fit more easily around everyday life ...

Prostate cancer is the most commonly diagnosed cancer in the UK, with more than 63,000 new cases each year. Yet for many men, understanding their treatment options remains far from straightforward ...

Partnering with University of Michigan Health represents an important step in bringing Unfold AI to leading cancer centers ...

Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...

These results correspond to an 80% reduction in the risk of death among patients surviving beyond five years.

The UK National Screening Committee (UK NSC) has rejected calls for population-wide prostate cancer screening using the PSA test. More than 63,000 men are diagnosed with prostate cancer annually in ...

Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of ...

Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...